B-type natriuretic peptide-guided treatment for heart failure. - Wikidata - thesis-toulmin - TriplyDB

B-type natriuretic peptide-guided treatment for heart failure.

B-type natriuretic peptide-guided treatment for heart failure.

http://www.wikidata.org/entity/Q30238936

about

Cardiac Hypertrophy and Brain Natriuretic Peptide Levels in an Ovariectomized Rat Model Fed a High-Fat Diet.

P2860

Q47115853-576F37B6-DFE4-4A1C-B05F-BF1B708A63B5

P2860

B-type natriuretic peptide-guided treatment for heart failure.

http://www.wikidata.org/entity/Q30238936

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

B-type natriuretic peptide-guided treatment for heart failure.

@ast

B-type natriuretic peptide-guided treatment for heart failure.

@en

type

label

B-type natriuretic peptide-guided treatment for heart failure.

@ast

B-type natriuretic peptide-guided treatment for heart failure.

@en

prefLabel

B-type natriuretic peptide-guided treatment for heart failure.

@ast

B-type natriuretic peptide-guided treatment for heart failure.

@en

P1433

Q30238936-3C8A5A59-C850-4F63-B783-C3C2BCB26E47

P1476

Q30238936-EFE0C0AE-6342-45BF-AB77-DFE3207FE124

P2093

Q30238936-10F43FC1-32E8-4A87-BB53-1861081E4968

Q30238936-3EA4B6EA-211D-4DD9-A837-AEB4A0FCFFC3

Q30238936-5C0AA55C-7FFC-4B50-8995-055AB89A1922

Q30238936-63644088-D668-4B6E-B55F-5B9BAD714E77

Q30238936-87A715A1-8182-41B5-A630-97D673F96570

Q30238936-931394F6-6F17-4EFA-A878-8FF0E16B0CCA

Q30238936-AA8A34A3-1E10-45D5-A92D-5B2BACFD5A6C

Q30238936-AFE59776-37F6-4121-B238-584FD726965B

Q30238936-C8CD5F6C-F2B0-405F-A918-A904DEC40B8C

P2860

Q30238936-04C69CFB-83A7-46FA-9FF8-E4CA31FFEF43

Q30238936-0A536A31-B4F1-4836-8243-8E6DEC46EF54

Q30238936-0B84E117-912C-4B43-BE62-4EF64EDA0C2E

Q30238936-0C39578E-EBFA-4000-81AE-1995B5646931

Q30238936-150F0A74-9D33-4818-A55B-AA5FEC2A995A

Q30238936-16638F91-8B31-4E0F-8940-BFB6D3F40C2F

Q30238936-18215003-72E2-4233-B52B-413D2D056648

Q30238936-20BB27C0-20EB-43DB-9CA3-791DE189BD5B

Q30238936-20CDEB5B-3500-40C3-8A64-6D086AD35206

Q30238936-227D412F-97B0-4114-B87D-3DA8DF6A5DD0

P304

Q30238936-4556C88E-0067-4D78-8559-21E99E92D565

P31

Q30238936-476BEFE8-CD43-4F19-81EA-B2DEFDB761C3

P356

Q30238936-6D57776A-000D-46E2-A3A2-B00EC98D1031

P478

Q30238936-4E19A201-EEFC-4D05-BDC6-4F75CECF2766

P50

Q30238936-830E0E8C-8CF1-4D93-8D39-1FE5CCBFC979

Q30238936-CA6BA1E3-6F45-44FC-8308-23E1DAF27768

P577

Q30238936-BAB3178D-BAD0-4A78-92E3-D3543517782C

P698

Q30238936-C2E0AB2A-04CD-4D5A-9F32-FD425FB86C5F

P932

Q30238936-AE0D3D2F-80BE-404A-83FE-67047B940EBC

P356

14651858.CD008966.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

B-type natriuretic peptide-guided treatment for heart failure.

@en

P2093

Alison M Clements

http://www.w3.org/2001/XMLSchema#string

Carl J Heneghan

http://www.w3.org/2001/XMLSchema#string

Clare Bankhead

http://www.w3.org/2001/XMLSchema#string

F Lucy Wright

http://www.w3.org/2001/XMLSchema#string

Karen E Kearley

http://www.w3.org/2001/XMLSchema#string

Nia W Roberts

http://www.w3.org/2001/XMLSchema#string

Nicola Pidduck

http://www.w3.org/2001/XMLSchema#string

Rafael Perera

http://www.w3.org/2001/XMLSchema#string

Sally Tyndel

http://www.w3.org/2001/XMLSchema#string

P2860

B-type natriuretic peptide-guided treatment for heart failure

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

Use of natriuretic peptides to guide and monitor heart failure therapy.

Trends in prevalence and outcome of heart failure with preserved ejection fraction

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the pro-B-type natriuretic peptide outpatient-tailored chronic heart failure therapy (PROTECT) study.

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.

A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction.

P304

CD008966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD008966.PUB2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Paul P. Glasziou

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28102899

http://www.w3.org/2001/XMLSchema#string

P932

5449577

http://www.w3.org/2001/XMLSchema#string